No Data
No Data
Colorectal Cancer (CRC) Pipeline Analysis Report 2024 Featuring Takeda, Eli Lilly and Co, Immatics Biotechnologies, Daiichi Sankyo., Millennium Pharmaceuticals Pfizer, and Bristol-Myers Squibb
Investors in Immatics (NASDAQ:IMTX) Have Unfortunately Lost 53% Over the Last Year
Is Immatics N.V. (IMTX) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
Down -16.85% in 4 Weeks, Here's Why Immatics (IMTX) Looks Ripe for a Turnaround
Immatics Advances PRAME Cell Therapy and Expands Oncology Pipeline
Immatics N.V.'s (NASDAQ:IMTX) Shares Lagging The Industry But So Is The Business